0 of 13 questions completed
You have already completed the assessment before. Hence you can not start it again.
Assessment is loading…
You must sign in or sign up to start the assessment.
You must first complete the following:
0 of 13 questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
TRUE or FALSE. SLL and CLL are considered to be the same B-cell malignancy.
What is the median age of a CLL patient at diagnosis?
Patients with an unmutated IGHV gene:
Which of the following symptoms would indicate initiating treatment?
Essentials tests for selecting first-line treatment are
Which of the following are treatment goals for first-line treatment?
Which of the following is an anti-CD20 antibody used for the treatment of CLL?
What would be the preferred first-line therapy for patients with mutated TP53 or 17p deletion?
For the FDA-approved indication of duvelisib (Copitkra®) for patients with relapsed/ refractory CLL, how many previous lines of therapy are required?
To avoid drug interactions, which of the following should be avoided when patients are receiving acalabrutinib (Calquence®)?
Which of the following are advised for managing side effects of chemoimmunotherapy?
As a member of the interprofessional team, nurses:
Resources for patients, caregivers, social workers and other HCPs can be found on websites including: